All other consultations cost $50, which we apply towards the cost of your procedure
For obesity treatment, dose escalation protocols starting at lower doses (e.g., 2 mg) and gradually increasing to maintenance doses (e.g., 4 mg, 8 mg, or 12 mg) have been studied Link below for more detailed information: Product Overview: Retatru/Cagrilintide is a dual-compound research peptide combining Retatru, a novel multi-agonist peptide with activity across GLP-1, GIP, and glucagon pathways, and Cagrilintide, an amylin analog
These compounds represent a surgical approach to endocrinology
The 5mg format provides researchers with a practical quantity of material suitable for multiple laboratory applications while supporting accurate measurement, handling, and experimental consistency
Furthermore, BPC 157 alters the expression of specific genes involved in vascular and cellular responses